Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 13, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

September 5, 2018

Conditions

Overactive Bladder

Interventions

DRUG

Meditoxin

Meditoxin (Botulinum toxin type A)

DRUG

Botox

Botox(Botulinum toxin type A)

Trial Locations (1)

Asan Medical Center, Seoul

All Listed Sponsors

lead

Medy-Tox

INDUSTRY

NCT03371342 - Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder | Biotech Hunter | Biotech Hunter